Clinical Trial Update: A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating the AAV-hAADC-2 gene therapy in subjects with Parkinson's disease. The study was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• AAV-hAADC-2 (AAV-hAADC-2)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED